48 related articles for article (PubMed ID: 10638983)
1. Cytokeratin expression profiles in thyroid carcinomas.
Lam KY; Lui MC; Lo CY
Eur J Surg Oncol; 2001 Nov; 27(7):631-5. PubMed ID: 11669590
[TBL] [Abstract][Full Text] [Related]
2. Clinical Relevance of Disseminated Tumor Cells in the Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients.
Müller V; Fehm T; Janni W; Gebauer G; Solomayer E; Pantel K
Breast Care (Basel); 2009 Nov; 4(5):333-338. PubMed ID: 30397407
[TBL] [Abstract][Full Text] [Related]
3. A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.
Alsina J; Alsina R; Gulec S
Mol Imaging Radionucl Ther; 2017 Feb; 26(Suppl 1):102-117. PubMed ID: 28117295
[TBL] [Abstract][Full Text] [Related]
4. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
[TBL] [Abstract][Full Text] [Related]
5. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.
Koch M; Kienle P; Hinz U; Antolovic D; Schmidt J; Herfarth C; von Knebel Doeberitz M; Weitz J
Ann Surg; 2005 Feb; 241(2):199-205. PubMed ID: 15650626
[TBL] [Abstract][Full Text] [Related]
6. Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation: a first step towards a molecular surrogate marker for neoadjuvant treatment in colorectal cancer.
Kienle P; Koch M; Autschbach F; Benner A; Treiber M; Wannenmacher M; von Knebel Doeberitz M; Büchler M; Herfarth C; Weitz J
Ann Surg; 2003 Sep; 238(3):324-30; discussion 330-1. PubMed ID: 14501498
[TBL] [Abstract][Full Text] [Related]
7. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
[TBL] [Abstract][Full Text] [Related]
8. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemistry of thyroid cancers. II. Medullary carcinomas (CMT) and "mixed" or "intermediate" tumors].
De Micco C
Ann Pathol; 1990; 10(5-6):297-312. PubMed ID: 1964783
[No Abstract] [Full Text] [Related]
10. Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction.
Weber T; Lacroix J; Weitz J; Amnan K; Magener A; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
Br J Cancer; 2000 Jan; 82(1):157-60. PubMed ID: 10638983
[TBL] [Abstract][Full Text] [Related]
11. Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction.
Weber T; Amann K; Weckauf H; Lacroix J; Weitz J; Schönfuss T; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
World J Surg; 2002 Feb; 26(2):148-52. PubMed ID: 11865340
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells detected by reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA: distinguishing follicular thyroid carcinoma from adenoma.
Sato T; Harao M; Nakano S; Jotsuka T; Suda N; Yamashita J
Surgery; 2005 May; 137(5):552-8. PubMed ID: 15855928
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
Bustin SA; Gyselman VG; Siddiqi S; Dorudi S
Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR.
Bojunga J; Röddiger S; Stanisch M; Kusterer K; Kurek R; Renneberg H; Adams S; Lindhorst E; Usadel KH; Schumm-Draeger PM
Br J Cancer; 2000 May; 82(10):1650-5. PubMed ID: 10817499
[TBL] [Abstract][Full Text] [Related]
15. Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients.
Kawamata H; Uchida D; Nakashiro K; Hino S; Omotehara F; Yoshida H; Sato M
Br J Cancer; 1999 May; 80(3-4):448-52. PubMed ID: 10408852
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
